Glioblastoma — radiation options
Prefer to look first? Browse the live map without signing up.
13 open options
- TRIALPHASE1 / PHASE2RECRUITING
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Pembrolizumab · Stereotactic Radiation Therapy · Surgical Resection — 1 site
- TRIALPHASE3RECRUITING
Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients
Biospecimen Collection · Chemical Exchange Saturation Transfer Magnetic Resonance Imaging · Diffusion-Relaxation Correlation Spectrum Imaging — 1 site
- TRIALPHASE2RECRUITING
Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study
Simultaneous-integrated boost with IMRT — 2 sites
- TRIALNARECRUITING
A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial
reduced target volume · EORTC (European organisation for research and treatment of cancer) target volume — 1 site
- TRIALPHASE2RECRUITING
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Intra-arterial Cetuximab · Intra-arterial Mannitol · Hypofractionated re-irradiation — 1 site
- TRIALPHASE1 / PHASE2NOT_YET_RECRUITING
Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)
ADI-PEG 20 (Arginine deiminase pegylated) · Temozolomide (TMZ) · Standard of Care Radiation Therapy (RT) — 1 site
- TRIALNANOT_YET_RECRUITING
Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor
Intraoperative Radiation Therapy in Malignant Cerebral Tumor
- TRIALPHASE2RECRUITING
Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow
Adaptive radiotherapy — 1 site
- TRIALPHASE1 / PHASE2RECRUITING
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Debio 0123 · Temozolomide · Radiotherapy — 16 sites
- TRIALPHASE1 / PHASE2RECRUITING
DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
DB107-RRV · DB107-FC · Radiation Therapy (RT) — 5 sites
- TRIALPHASE3RECRUITING
Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
Lomustine · Reirradiation — 45 sites
- TRIALPHASE2 / PHASE3NOT_YET_RECRUITING
Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer
Intensity-Modulated Radiation Therapy · Hypofractionated Radiation Therapy · Temozolomide (TMZ)
- TRIALPHASE2RECRUITING
Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread
Intrathecal injection of thiotepa · Stupp regimen (oral temozolomide) · Radical radiotherapy — 1 site
Live from ClinicalTrials.gov, refreshed at most hourly · registry query ↗
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.